| Product Code: ETC12772960 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ethiopia Non-Small Cell Lung Cancer Market Overview |
3.1 Ethiopia Country Macro Economic Indicators |
3.2 Ethiopia Non-Small Cell Lung Cancer Market Revenues & Volume, 2021 & 2031F |
3.3 Ethiopia Non-Small Cell Lung Cancer Market - Industry Life Cycle |
3.4 Ethiopia Non-Small Cell Lung Cancer Market - Porter's Five Forces |
3.5 Ethiopia Non-Small Cell Lung Cancer Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Ethiopia Non-Small Cell Lung Cancer Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Ethiopia Non-Small Cell Lung Cancer Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Ethiopia Non-Small Cell Lung Cancer Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Ethiopia Non-Small Cell Lung Cancer Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about lung cancer screening and early detection programs |
4.2.2 Growing adoption of advanced treatment options and therapies for non-small cell lung cancer |
4.2.3 Rise in healthcare infrastructure and investments in oncology care in Ethiopia |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare facilities and oncology expertise in remote areas of Ethiopia |
4.3.2 High cost of advanced cancer treatments and therapies leading to affordability issues for patients |
5 Ethiopia Non-Small Cell Lung Cancer Market Trends |
6 Ethiopia Non-Small Cell Lung Cancer Market, By Types |
6.1 Ethiopia Non-Small Cell Lung Cancer Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Ethiopia Non-Small Cell Lung Cancer Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Ethiopia Non-Small Cell Lung Cancer Market Revenues & Volume, By Adenocarcinoma, 2021 - 2031F |
6.1.4 Ethiopia Non-Small Cell Lung Cancer Market Revenues & Volume, By Squamous Cell Carcinoma, 2021 - 2031F |
6.1.5 Ethiopia Non-Small Cell Lung Cancer Market Revenues & Volume, By Large Cell Carcinoma, 2021 - 2031F |
6.1.6 Ethiopia Non-Small Cell Lung Cancer Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Ethiopia Non-Small Cell Lung Cancer Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Ethiopia Non-Small Cell Lung Cancer Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.2.3 Ethiopia Non-Small Cell Lung Cancer Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.2.4 Ethiopia Non-Small Cell Lung Cancer Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.2.5 Ethiopia Non-Small Cell Lung Cancer Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.3 Ethiopia Non-Small Cell Lung Cancer Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Ethiopia Non-Small Cell Lung Cancer Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Ethiopia Non-Small Cell Lung Cancer Market Revenues & Volume, By Oncology Clinics, 2021 - 2031F |
6.3.4 Ethiopia Non-Small Cell Lung Cancer Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.3.5 Ethiopia Non-Small Cell Lung Cancer Market Revenues & Volume, By Specialty Centers, 2021 - 2031F |
6.4 Ethiopia Non-Small Cell Lung Cancer Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Ethiopia Non-Small Cell Lung Cancer Market Revenues & Volume, By Cancer Treatment, 2021 - 2031F |
6.4.3 Ethiopia Non-Small Cell Lung Cancer Market Revenues & Volume, By Tumor Management, 2021 - 2031F |
6.4.4 Ethiopia Non-Small Cell Lung Cancer Market Revenues & Volume, By Clinical Trials, 2021 - 2031F |
6.4.5 Ethiopia Non-Small Cell Lung Cancer Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
7 Ethiopia Non-Small Cell Lung Cancer Market Import-Export Trade Statistics |
7.1 Ethiopia Non-Small Cell Lung Cancer Market Export to Major Countries |
7.2 Ethiopia Non-Small Cell Lung Cancer Market Imports from Major Countries |
8 Ethiopia Non-Small Cell Lung Cancer Market Key Performance Indicators |
8.1 Percentage increase in the number of lung cancer screenings conducted annually |
8.2 Adoption rate of targeted therapies and immunotherapies for non-small cell lung cancer |
8.3 Number of oncology specialists trained and practicing in Ethiopia |
8.4 Patient survival rates post-diagnosis and treatment |
8.5 Rate of government and private sector investments in oncology care infrastructure and facilities |
9 Ethiopia Non-Small Cell Lung Cancer Market - Opportunity Assessment |
9.1 Ethiopia Non-Small Cell Lung Cancer Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Ethiopia Non-Small Cell Lung Cancer Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Ethiopia Non-Small Cell Lung Cancer Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Ethiopia Non-Small Cell Lung Cancer Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Ethiopia Non-Small Cell Lung Cancer Market - Competitive Landscape |
10.1 Ethiopia Non-Small Cell Lung Cancer Market Revenue Share, By Companies, 2024 |
10.2 Ethiopia Non-Small Cell Lung Cancer Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here